Creo Medical Group PLC (AIM: CREO)
London
· Delayed Price · Currency is GBP · Price in GBX
19.00
0.00 (0.00%)
Jan 17, 2025, 3:33 PM GMT+1
Creo Medical Group Revenue
Creo Medical Group had revenue of 15.20M GBP in the half year ending June 30, 2024, with 11.76% growth. This brings the company's revenue in the last twelve months to 30.30M, up 3.41% year-over-year. In the year 2023, Creo Medical Group had annual revenue of 30.80M with 13.24% growth.
Revenue (ttm)
30.30M
Revenue Growth
+3.41%
P/S Ratio
2.14
Revenue / Employee
108.99K
Employees
287
Market Cap
72.39M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 30.80M | 3.60M | 13.24% |
Dec 31, 2022 | 27.20M | 2.04M | 8.10% |
Dec 31, 2021 | 25.16M | 15.73M | 166.85% |
Dec 31, 2020 | 9.43M | 9.42M | 69,884.41% |
Dec 31, 2019 | 13.47K | - | - |
Dec 31, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Feb 29, 2016 | Pro | Pro | Pro |
Feb 28, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |